Categories: NewsPharmaceutical

Laxxon Medical to Participate in 27th Annual Needham Growth Conference

NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals, today announced that management is participating in the 27th Annual Needham Growth Conference on January 9-17th, 2024.

Laxxon CEO/Chairman Helmut Kerschbaumer and Chief Strategy Officer Alexander Ruckdaeschel will participate in one-on-one meetings with institutional, private equity, and venture capital investors.

For more information about the conference or to schedule a one-on-one meeting with Laxxon Medical, please get in touch with your Needham representative.

About Laxxon Medical

Laxxon Medical is a leading pharma-technology company and global leader of smart drug delivery systems in the pharmaceutical industry, pioneering a new generation of advanced pharmaceuticals designed to optimize drug delivery and maximize patient success through SPID®-Technology, Laxxon’s proprietary 3DSP technology platform.

SPID®-Technology unlocks innovative drug delivery advancements paired with fast-tracked market access and extensive IP protection to yield disruptive opportunities in drug development and commercialization.

With SPID®-Technology, Laxxon can develop and manufacture advanced versions of new and existing pharmaceutical drugs while extending and adding new patent protection through the technology transfer process. Laxxon can fully utilize the FDA’s 505b(2) regulatory pathway in the US and Hybrid applications under article 10(3) of Directive 2001/83/EC in the EUR, which fast tracks product routes to market.

Laxxon’s pipeline includes ongoing working-projects with notable pharma players, biotech companies and research universities, in addition to 13 in-house Advanced Patented Generics products. Laxxon’s IP is continuously growing, and together with the licensed IP from Exentis Group, consists of > 230 patents and patent applications with more than 5,000 patent claims.

Learn more at www.laxxonmedical.com.

SOURCE: Laxxon Medical

View the original press release on accesswire.com

Staff

Recent Posts

Real Time Medical Systems to Present Strategies for Enhancing Value-Based Outcomes and Quality Improvement at 2025 AHCA/NCAL Quality Summit

Clinical leaders to share actionable insights on leveraging live data analytics to drive value-based care…

1 hour ago

LEADING WOMEN’S HEALTH COMPANY O POSITIV FEATURED ON TIKTOK SHOP SUPER BRAND DAY

O Positiv to Offer Discounts and Exclusive Content on TikTok Shop April 7th - 13th,…

1 hour ago

NBPure Tackles America’s Fiber Deficiency with More Complete Daily Multi-Fiber

PHOENIX, April 7, 2025 /PRNewswire/ -- Renowned for its commitment to optimal gut health solutions,…

1 hour ago

Bosch establishes company with the synthetic diamond solutions provider Element Six

Quantum sensors: Partnership to extend innovation leadership Element Six and the technology company Bosch are…

1 hour ago

Therapy Brands Is Now Ensora Health

New name and brand identity reflect commitment to creating harmony between therapists, clients and broader…

1 hour ago